Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

LabAnswer and OpGen implement the STARLIMS Cloud Platform to Support OpGen’s CLIA Certified Clinical Services Laboratory in Under Four Months

Published: Tuesday, August 13, 2013
Last Updated: Tuesday, August 13, 2013
Bookmark and Share
LabAnswer provides end-to-end service solution for OpGen to support their new clinical laboratory using the latest Laboratory Information Management System (LIMS) cloud platform technology.

LabAnswer has announced the implementation of a cloud based, HIPAA compliant system to support OpGen’s newly launched clinical services laboratory. This CLIA certified laboratory will focus on developing a best-in-class portfolio of genetic tests and analysis services for the surveillance and identification of healthcare associated infections (HAIs) and human pathogens. Next generation DNA and genetic analysis technologies generate a tremendous amount of sequencing data that benefits significantly from automated scientific data management that a LIMS system provides.

OpGen contacted LabAnswer for assistance in implementing a system to support the launch of their new clinical laboratory services. With a requirement to have a system up and running in less than four months, OpGen selected LabAnswer because of its depth and breadth of experience in providing complete end-to-end service solutions with capabilities to take a system’s implementation from strategy and planning, through solution implementation and then ongoing support. LabAnswer brought to bear subject matter experts with hands on experience running labs, superb design and requirements gathering skills, configuration expertise, and project management and execution methodologies to make this a reality.

LabAnswer and OpGen identified the STARLIMS Cloud Platform as the enterprise information system to support the laboratory. The STARLIMS application provides configurable functionality to support business functions required by the clinical lab. Deploying via a cloud platform provides many benefits including no upfront capital or hardware costs, secure infrastructure, data privacy controls, and flexibility needed to rapidly develop and deploy an application. As business demand for the clinical services increases, the cloud platform will also be able to continuously scale without hardware upgrade projects.

At the onset, LabAnswer and OpGen formulated both strategic and tactical plans to deliver highest value functionality within strict business deadlines. In a strategic planning capacity, LabAnswer defined implementation scope by defining vision, goals and objectives, creating business process workflows and eliciting requirements.  After the initial scope was defined, the teams worked together to prioritize critical system and high value functions to be implemented in the LIMS, and relegated lesser value functions to an enhancement queue. In parallel, the STARLIMS Cloud Platform was setup to support the configuration, testing and deployment phases of the project. LabAnswer developed the system in an iterative prototyping model that kept the OpGen team constantly engaged in the evolution of the system.  As the system development entered into the final phase, LabAnswer executed the training and data prep for system go live in July.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

LabAnswer and Kona DataSearch Announce Partnership
Partners will work collaboratively on building and jointly providing customers with integrated solutions.
Wednesday, April 02, 2014
LabAnswer Selects John F. Conway as Director of R & D Strategy
New position will strategize and architect scientific data management systems.
Tuesday, February 25, 2014
LabAnswer Receives Prime Award for CIO-SP3 Contract
LabAnswer is set to Provide Market-Leading Scientific Data Management and Laboratory Informatics Services to Federal Agencies through Government-Wide Acquisition Contract
Tuesday, July 31, 2012
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!